Measure, monitor, and track endoscopic disease activity in your adult Crohn’s disease (CD) patients with 1 simple serum test
Improvement in mucosal damage provides an objective measure of therapeutic response in CD management.1 However,
current assessment methods may not provide
needed information, particularly when evaluating disease activity in difficult-to-reach
locations to assess ileal disease.1-3
The PROMETHEUS® Monitr™ Crohn’s Disease Test is a laboratory-developed test that evaluates multiple markers of mucosal damage and
repair processes, regardless of disease location.4 It applies a proprietary algorithm to 13 biomarkers to produce
a quantitative Endoscopic Healing Index (EHI) Score—ranging from 0 to 100—to aid in distinguishing endoscopic remission from
active disease in adult CD patients.